Go to AAD Home
Donate For Public and Patients Store Search
Go to AAD Home
Main menu
Membership
Meetings & Education
Practice management
Clinical & quality
Publications & apps
Career development
Advocacy
Back
Account
Pay dues
Member ID
Join the AAD
Member benefits
Find a member
AAD election
AAD governance
Support AAD
AAD Help Center
2024 Innovation Academy
2025 Annual Meeting
Academy meetings archive
Professional Education
Claim CME & view transcript
Upcoming events
Residents & medical students
Patient education materials
DataDerm
Coding Resource Center
MIPS & fee schedule
Teledermatology
EHR & health tech
Insurance & drugs
Compliance & practice scope
Managing your practice
Clinical guidelines
Quality measures
DataDerm
Quality & patient safety
Clinical Community
Clinical care resources
Position statements
JAAD
JAAD International
JAAD Case Reports
Dermatology World
DermWorld Insights & Inquiries
Derm Coding Consult
DermWorld Meeting News
Impact Report
Other publications
Academy Apps
Job board
Join or sell a practice
Burnout & wellness
Career launch
Diversity
Awards, grants, and scholarships
Leadership Institute
Volunteer opportunities
Ethics & professionalism
Take action
Advocacy priorities
State advocacy resources
Legislative Conference
Position statements
Promote the specialty
Key Contacts
Patient advocate resources
SkinPAC
Advocacy Update
Welcome!

AAD Statement on USPSTF Recommendation on Skin Cancer Screening

Statement from Terrence Cronin Jr., MD, FAAD, President, American Academy of Dermatology

ROSEMONT, Ill. (April 18, 2023) — “In its Recommendation Statement on Screening for Skin Cancer, the U.S. Preventive Services Task Force — a group that provides guidance for primary care physicians — has determined that there is not enough scientific evidence to make a recommendation about adults receiving skin cancer screenings from their primary care doctor.

“It is important for the public to understand that the USPSTF is not recommending against skin cancer screenings or commenting on the value of general population screening by dermatologists, who are the leading experts in diagnosis and treatment of skin cancer.

“Skin cancer is highly treatable when diagnosed early. Melanoma accounts for the vast majority of skin cancer deaths, and nonmelanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma can have potentially devastating effects, including severe tissue loss, metastasis, and death.

“The AAD encourages everyone to serve as their own health advocate by regularly conducting skin self-exams. Individuals who notice any new spots on their skin, any spots that look different from the others, or anything changing, itching or bleeding, should see a board-certified dermatologist. While everyone is at risk of developing skin cancer, some individuals have a higher risk and should be particularly vigilant. Consult with your dermatologists who knows what your individual skin cancer risk is.”

Contact

Media Relations, mediarelations@aad.org

About the AAD

Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 20,000 physicians worldwide, the AAD is committed to advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair, and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care because skin, hair, and nail conditions can have a serious impact on your health and well-being. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow @AADskin on Instagram, Facebook, Pinterest, and YouTube.